Advertisement
-
-
Interferon disrupts immune and tissue homeostasis in SLE via CXCL13
Type I interferon has a crucial role in the immunopathogenesis of systemic lupus erythematosus (SLE). Analysis of CD4+ T cells from individuals with SLE now shows that type I interferon intervenes with the transcriptional regulators AHR and JUN to downregulate expression of IL-22, which promotes tissue regeneration, and upregulate the expression of CXCL13, which supports lymphoid structure formation.
-
-
25 years of biologic therapy
Trending - Altmetric
-
Epidemiology of sarcopenia and insight into possible therapeutic targets
-
Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges
-
Phenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapy
-
Recent advancements in cartilage tissue engineering innovation and translation